Affordable Access

Distance to the neurooncological center: a negative prognostic factor in patients with glioblastoma multiforme. An epidemiological study.

Authors
Type
Published Article
Journal
Anticancer Research
1791-7530
Publisher
International Institute of Anticancer Research
Publication Date
Volume
32
Issue
12
Pages
5515–5519
Identifiers
PMID: 23225460
Source
Medline
License
Unknown

Abstract

The distance to the neurooncological center negatively-influenced the prognosis of patients with GBM. Patients were less often treated with adjuvant chemotherapy in the pre-temozolomide era with increasing distance to the neurooncological center. Although the introduction of temozolomide as the standard chemotherapeutic agent in GBM treatment changed this fact, the influence of the distance to the specialized center should be kept in mind as a prognostic factor for this disease.

Statistics

Seen <100 times